期刊文献+

肿瘤标志物联合检测对恶性胸腹腔积液的诊断价值 被引量:4

Diagnostic value of combined detection of various tumor markers in malignant hydrothorax and hydroperitoneum
下载PDF
导出
摘要 目的分析甲胎蛋白(AFP)、癌胚抗原(CEA)、糖链抗原125(CA125)、神经元特异性烯醇化酶(NSE)、糖链抗原724(CA724)联合检测对恶性胸腹腔积液的诊断价值。方法以细胞病理学诊断为金标准,采用受试者工作特征曲线(ROC曲线)确定肿瘤标志物对291例恶性胸腹腔积液的诊断临界值,以135例良性胸腹腔积液为对照,研究肿瘤标志物单独及联合检测对恶性胸腹腔积液的诊断价值。结果 ROC曲线分析结果显示,CEA、CA724诊断恶性胸腹腔积液的ROC曲线下面积均超过0.7,具有较高诊断价值。CEA、CA724、NSE、CA125单独检测时,以CEA灵敏度(81.7%)、约登指数(0.64)、阴性预测值(67.7%)、阳性预测值(90.8%)较高,特异度则以NSE(82.9%)较高。联合检测的诊断灵敏度、约登指数、阴性预测值较单独检测均有不同程度的提高。结论 CEA对恶性胸腹腔积液具有较高的诊断价值,多肿瘤标志物联合检测可提高诊断灵敏度、约登指数、阴性预测值。 Objective To explore Diagnostic value of combined detection of alpha fetoprotein(AFP),carcino-embryonic antigen(CEA),carbohydrate antigen 125(CA125),neurone specific enolase(NSE)and carbohydrate antigen 724(CA724)in malignant hydrothorax and hydroperitoneum.Methods According to the pathological diagnosis as gold standard,receiver operating characteristic(ROC)curve was used to analyzed the cut-off value for the diagnosis of malignant hydrothorax and hydroperitoneum in 291 patients,and 135 patients with benign malignant hydrothorax and hydroperitoneum were enrolled as controls.Diagnostic value of single and combined detection of tumor markers was analyzed.Results Area under the ROC curve of CEA and CA724 were higher than 0.7,indicating that CEA and CA724 were with high diagnostic value.Among CEA,CA724,NSE and CA125,used for single detection,CEA was with high sensitivity(81.7%),Jorden index(0.64),negative predictive value(67.7%),positive predictive value(90.8%),and NSE(82.9%)was with high specificity.Combined detection of tumor markers could increase diagnostic sensitivity,Jorden index and negative predictive value.Conclusion CEA could be with high diagnostic value of malignant hydrothorax and hydroperitoneum.Combined detection of tumor markers could increase diagnostic sensitivity,Jorden index and negative predictive value.
作者 张惠琴
出处 《国际检验医学杂志》 CAS 2015年第21期3131-3132,3136,共3页 International Journal of Laboratory Medicine
关键词 肿瘤标志物 胸腹腔积液 恶性 良性 tumor marker hydrothorax and hydroperitoneum malignant benign
  • 相关文献

参考文献12

  • 1Bignotti E, Ragnoli M, Zanotti L, et al. Diagnostic and prognostic impact of serum HE4 detection inendometrial carcinoma patients [J]. Br J Cancer,2011,104(9) : 1418-1425.
  • 2Molina R, Auge JM, Bosch X, et al. Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer:correlation with histology[J]. Tumour Biol, 2009,30 (3) ,121-129.
  • 3邹焱,何小兵,潘静,杨纪亮,杨天佑.实时定量荧光聚合酶链反应检测神经母细胞瘤患儿血清中MYCN基因表达[J].中华实验外科杂志,2015,32(1):198-198. 被引量:4
  • 4Montagnana M, Lippi G, Ruzzenente O, et al. The utility of serum human ePididymis Protein4 (HE4) in Patients with apelvic mass [J]. J Clin Lab Anal,2009,23(5):334-335.
  • 5陈栎江,张文辉,唐恩燕,屠鸿翔,虞丹丹,吴莲凤.Logistic回归和ROC曲线分析多种肿瘤标志物在鉴别良恶性胸水中的应用价值[J].实用医学杂志,2009,25(2):238-240. 被引量:12
  • 6Kulpa JK,Saskorczyoska B. ProGRP and NSE in therapy monito- ring in patients with small cell lung caneer[J]. Anticancer Res, 2008,28(5B) :3027-3033.
  • 7周萍,郭炫,陈葳,封婧,陶丹,何晓璇,王聪,王晓琴.肿瘤标志物联合检测在胸腹水性质鉴别中的临床应用[J].现代肿瘤医学,2014,22(3):664-666. 被引量:16
  • 8Kira H, Marina B, Matthias P, et al. Soluble carcinoembryonic an- tigen activates endothelial cells and tumor angiogenesis[J]. Cancer Res, 2013,73(22) : 6584-6596.
  • 9Yun P,Zhao CP, Ruan H, et al. Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profi- ling[J]. Cancer,2012,118(3) :639-650.
  • 10Anabella A, Ivancich LJ, Donald J, et al. Spectroscopic and kinetic investigation ozf the reactions of peroxyacetic acid with Burkholde- ria pseudomallei catalase-peroxidase, KatG[J]. Biochemistry, 2013,52(41) :7271-7282.

二级参考文献34

  • 1肖创清,蒋立,周光华,何云南.胸水多项肿瘤标志物检测的临床价值[J].放射免疫学杂志,2005,18(2):141-142. 被引量:19
  • 2王英,黄玲莎,黄文成.三种血清肿瘤标志物在肺癌诊断中的临床价值[J].医学临床研究,2006,23(5):661-662. 被引量:13
  • 3应海平.胸水ADA和CEA检测在胸腔积液中的鉴别诊断价值[J].现代实用医学,2006,18(6):390-390. 被引量:17
  • 4冯晨,唐锁勤,王建文,刘立真,高晓宁,龙卉.荧光定量RT-PCR检测神经母细胞瘤细胞MYCN基因mRNA的表达[J].中国当代儿科杂志,2007,9(1):47-50. 被引量:3
  • 5Alatas F, Alatas O, Metintas M, et al. Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1,NSE and TSA assay in pleural effusions [J]. Lung Cancer, 2001,31 ( 1 ) : 9-16.
  • 6Shitrit D, Zingerman B, Shitrit A B, et al. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA125 assays in pleural effusions: analysis of 116 cases and review of the literature [J]. Oncologist, 2005,10 (7) : 501-507.
  • 7Lee J H, Chang J H. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung caneer [J]. Chest, 2005,128 (4) : 2298-2303.
  • 8Trape J, Molina R, Sant F. Clinical evaluation of the simultaneous determination of tumor markers in fluid and serum and their ratio in the differential diagnosis of serous effusions [J]. Tumour Biol,2004, 25(5-6) :276-281.
  • 9Schneider J, Velcovsky H G, Morr H, et al. Comparison of the tumor markers tumor M2-PK,CEA,CYFRA21-1,NSE and SCC in the diagnosis of lung cancer [J]. Anti-cancer Res, 2000,20 (6D) : 5053- 5058.
  • 10Hatzakis K D, Froudarakis M E, Bourns D, et al. Prognostic value of serum tumor markers in patients with lung cancer [J]. Respiration, 2002,69 ( 1 ) : 25-29.

共引文献48

同被引文献31

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部